ISS A/S
Treasury shares exceeding 5% of share capital
Treasury shares exceeding 5% of share capital
Company Announcement
Copenhagen, 29 September 2025
No. 56/2025
Treasury shares exceeding 5% of share capital
As of 26 September 2025, ISS A/S held 5.03% of the share capital and voting rights in the Company, cf. the Danish Capital Markets Act, section 31. Due to the ongoing share buy-back program, ISS has increased its holding of treasury shares to exceed 5% of the share capital.
Through the programme, ISS wishes to redistribute excess cash to shareholders. The purpose of the share buy-back programme is to (i) reduce the share capital and (ii) meet obligations arising from ISS’ share-based incentive programmes.
For investor enquiries
Michael Vitfell-Rasmussen, Head of Group Investor Relations, +45 53 53 87 25
Anne Sophie Riis, Senior Investor Relations Manager, + 45 30 52 94 68
For media enquiries
Charlotte Holm, Head of External Communication, +45 41 76 19 89
ISS is a leading, global provider of workplace and facility service solutions. In partnership with customers, ISS drives the engagement and well-being of people, minimises the impact on the environment, and protects and maintains property. ISS brings all of this to life through a unique combination of data, insight and service excellence at offices, factories, airports, hospitals and other locations across the globe. ISS has more than 325,000 employees around the globe, who we call “placemakers”. In 2024, Group revenue was DKK 83.7 billion. For more information on the ISS Group, visit www.issworld.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG29.9.2025 14:15:00 CEST | Press release
Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US
Cosmos Health Inc.29.9.2025 14:00:07 CEST | Press release
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
DLR Kredit A/S29.9.2025 13:51:03 CEST | Pressemeddelelse
Fastsættelse af kuponrenter (Senior, Non-Preferred Note)
Novartis Pharma AG29.9.2025 13:44:34 CEST | Press release
Novartis announces commencement of tender offer to acquire Tourmaline Bio
Djurslands Bank A/S29.9.2025 13:42:07 CEST | Pressemeddelelse
Aktietilbagekøb i Djurslands Bank – transaktioner i uge 39
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom